Friedman, M. D., Lacouture, M., & Dang, C. (2015). Dermatologic Adverse Events Associated with use of Adjuvant Lapatinib in Combination with Paclitaxel and Trastuzumab for HER2 positive Breast Cancer: A Case Series Analysis. Clin Breast Cancer.
Chicago-стиль цитированияFriedman, Marissa D., Mario Lacouture, and Chau Dang. "Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2 Positive Breast Cancer: A Case Series Analysis." Clin Breast Cancer 2015.
MLA-цитированиеFriedman, Marissa D., Mario Lacouture, and Chau Dang. "Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2 Positive Breast Cancer: A Case Series Analysis." Clin Breast Cancer 2015.